U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 28

1.
Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer
Jiatao Liao, Hongyan Lai, Chang Liu, Xin Zhang, Qiuxiang Ou, Qiaojuan Li, Yan Li, Zhen Wang, Cuicui Liu, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Xinmin Zhao, Zhihuang Hu, Yao Zhang, Ying Lin, Bo Yu, Shenglin Huang, Jialei Wang
Cancer Sci. 2023 Jul; 114(7): 2774–2786. Published online 2023 Apr 20. doi: 10.1111/cas.15804
PMCID:
PMC10323081
AbstractArticlePDF–3.7M
2.
The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma
Marie-Léa Gauci, Jérôme Giustiniani, Clémence Lepelletier, Christian Garbar, Nicolas Thonnart, Nicolas Dumaz, Arnaud Foussat, Céleste Lebbé, Armand Bensussan, Anne Marie-Cardine
Cancer Immunol Immunother. 2022 Nov; 71(11): 2731–2742. Published online 2022 Apr 15. doi: 10.1007/s00262-022-03199-0
PMCID:
PMC9519731
AbstractArticlePDF–1.1M
3.
CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression
Zheng Sun, Yidi Li, Zining Zhang, Yajing Fu, Xiaoxu Han, Qinghai Hu, Haibo Ding, Hong Shang, Yongjun Jiang
Front Immunol. 2022; 13: 854432. Published online 2022 Aug 19. doi: 10.3389/fimmu.2022.854432
PMCID:
PMC9469471
AbstractArticlePDF–9.3M
4.
Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study
Weiwei He, Jing Zhao, Xuerong Liu, Sheli Li, Kaida Mu, Jing Zhang, Jin-an Zhang
BMC Endocr Disord. 2021; 21: 148. Published online 2021 Jul 8. doi: 10.1186/s12902-021-00810-w
PMCID:
PMC8268507
AbstractArticlePDF–559K
5.
Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia
Najmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, Lai Xu, Amelie Fontaine, Nanette Cox-Kennett, Loree M Larratt, Mark Hnatiuk, Andrei Fagarasanu, Joseph Brandwein, Anthea C Peters, Shokrollah Elahi
J Immunother Cancer. 2021; 9(4): e002189. Published online 2021 Apr 30. doi: 10.1136/jitc-2020-002189
PMCID:
PMC8098955
AbstractArticlePDF–5.0M
6.
Structural Basis of CD160:HVEM Recognition
Weifeng Liu, Sarah C. Garrett, Elena V. Fedorov, Udupi A. Ramagopal, Scott J. Garforth, Jeffrey B. Bonanno, Steven C. Almo
Structure. Author manuscript; available in PMC 2020 Sep 8.
Published in final edited form as: Structure. 2019 Aug 6; 27(8): 1286–1295.e4. Published online 2019 Jun 20. doi: 10.1016/j.str.2019.05.010
PMCID:
PMC7477951
AbstractArticlePDF–2.1M
7.
Differential and tumor-specific expression of CD160 in B-cell malignancies
Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal
Blood. 2011 Aug 25; 118(8): 2174–2183. Prepublished online 2011 Jun 28. doi: 10.1182/blood-2011-02-334326
PMCID:
PMC5292591
AbstractArticle
8.
Increased CD160 expression on circulating natural killer cells in atherogenesis
Jin Zuo, Zhaoliang Shan, Lin Zhou, Jian Yu, Xiaopeng Liu, Yuan Gao
J Transl Med. 2015; 13: 188. Published online 2015 Jun 13. doi: 10.1186/s12967-015-0564-3
PMCID:
PMC4467674
AbstractArticlePDF–2.5M
9.
Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia
T W Farren, J Giustiniani, M Fanous, F Liu, M G Macey, F Wright, A Prentice, A Nathwani, S G Agrawal
Blood Cancer J. 2015 Jan; 5(1): e273. Published online 2015 Jan 23. doi: 10.1038/bcj.2014.92
PMCID:
PMC4314455
AbstractArticlePDF–438K
10.
CD160 isoforms and regulation of CD4 and CD8 T-cell responses
Mohamed El-Far, Charles Pellerin, Louise Pilote, Jean-Francois Fortin, Ivan A D Lessard, Yoav Peretz, Elizabeth Wardrop, Patrick Salois, Richard C Bethell, Michael G Cordingley, George Kukolj
J Transl Med. 2014; 12: 217. Published online 2014 Sep 2. doi: 10.1186/s12967-014-0217-y
PMCID:
PMC4163173
AbstractArticlePDF–2.2M
11.
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Sophie Chabot, Nabila Jabrane-Ferrat, Karine Bigot, Julie Tabiasco, Alexandra Provost, Muriel Golzio, Muhammad Zaeem Noman, Jérôme Giustiniani, Elisabeth Bellard, Stéphanie Brayer, Maryse Aguerre-Girr, Fabienne Meggetto, Sylvie Giuriato, François Malecaze, Stéphane Galiacy, Jean-Philippe Jaïs, Olivier Chose, Jean Kadouche, Salem Chouaib, Justin Teissié, Marc Abitbol, Armand Bensussan, Philippe Le Bouteiller
J Exp Med. 2011 May 9; 208(5): 973–986. doi: 10.1084/jem.20100810
PMCID:
PMC3092350
AbstractArticlePDF–3.1M
12.
BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity.
A Bensussan, E Gluckman, S el Marsafy, V Schiavon, I G Mansur, J Dausset, L Boumsell, E Carosella
Proc Natl Acad Sci U S A. 1994 Sep 13; 91(19): 9136–9140. doi: 10.1073/pnas.91.19.9136
PMCID:
PMC44762
SummaryPage BrowsePDF–1.0M
13.
CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells
Linxia Zhang, Anli Zhang, Jun Xu, Chao Qiu, Lingyan Zhu, Chenli Qiu, Weihui Fu, Ying Wang, Lilin Ye, Yang-xin Fu, Chen Zhao, Xiaoyan Zhang, Jianqing Xu
Front Immunol. 2020; 11: 2188. Published online 2020 Sep 11. doi: 10.3389/fimmu.2020.02188
PMCID:
PMC7533580
AbstractArticlePDF–3.8M
14.
CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia
Feng-Ting Liu, Jerome Giustiniani, Timothy Farren, Li Jia, Armand Bensussan, John G. Gribben, Samir G. Agrawal
Blood. 2010 Apr 15; 115(15): 3079–3088. Prepublished online 2010 Feb 17. doi: 10.1182/blood-2009-08-239483
PMCID:
PMC5292590
AbstractArticle
15.
Biased GsVersus Gq Proteins and β-Arrestin Signaling in the NK1 Receptor Determined by Interactions in the Water Hydrogen Bond Network
Louise Valentin-Hansen, Thomas M. Frimurer, Jacek Mokrosinski, Nicholas D. Holliday, Thue W. Schwartz
J Biol Chem. 2015 Oct 2; 290(40): 24495–24508. Published online 2015 Aug 12. doi: 10.1074/jbc.M115.641944
PMCID:
PMC4591830
AbstractArticlePDF–3.2M
16.
CD160 Activation by Herpesvirus Entry Mediator Augments Inflammatory Cytokine Production and Cytolytic Function by NK cells
John R. Šedý, Ryan L. Bjordahl, Vasileios Bekiaris, Matthew G. Macauley, Brian C. Ware, Paula S. Norris, Nell S. Lurain, Chris A. Benedict, Carl F. Ware
J Immunol. Author manuscript; available in PMC 2014 Jul 15.
Published in final edited form as: J Immunol. 2013 Jul 15; 191(2): 828–836. Published online 2013 Jun 12. doi: 10.4049/jimmunol.1300894
PMCID:
PMC3702646
AbstractArticlePDF–1.2M
17.
Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation
Jérôme Giustiniani, Armand Bensussan, Anne Marie-Cardine
J Immunol. Author manuscript; available in PMC 2012 Oct 18.
Published in final edited form as: J Immunol. 2009 Jan; 182(1): 63–71. doi: 10.4049/jimmunol.182.1.63
PMCID:
PMC3472403
AbstractArticle
18.
CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
Yoav Peretz, Zhong He, Yu Shi, Bader Yassine-Diab, Jean-Philippe Goulet, Rebeka Bordi, Ali Filali-Mouhim, Jean-Baptiste Loubert, Mohamed El-Far, Franck P. Dupuy, Mohamed Rachid Boulassel, Cécile Tremblay, Jean-Pierre Routy, Nicole Bernard, Robert Balderas, Elias K. Haddad, Rafick-Pierre Sékaly
PLoS Pathog. 2012 Aug; 8(8): e1002840. Published online 2012 Aug 16. doi: 10.1371/journal.ppat.1002840
PMCID:
PMC3420930
AbstractArticlePDF–668K
19.
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160
Weifeng Liu, Ting-Fang Chou, Sarah C. Garrett-Thomson, Goo-Young Seo, Elena Fedorov, Udupi A. Ramagopal, Jeffrey B. Bonanno, Qingyang Wang, Kenneth Kim, Scott J. Garforth, Kiyokazu Kakugawa, Hilde Cheroutre, Mitchell Kronenberg, Steven C. Almo
J Exp Med. 2021 Dec 6; 218(12): e20211112. Published online 2021 Oct 28. doi: 10.1084/jem.20211112
PMCID:
PMC8558838
AbstractArticlePDF–7.0M
20.
Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity
Philippe Le Bouteiller, Aliz Barakonyi, Jérome Giustiniani, Françoise Lenfant, Anne Marie-Cardine, Maryse Aguerre-Girr, Magali Rabot, Ivan Hilgert, Fathia Mami-Chouaib, Julie Tabiasco, Laurence Boumsell, Armand Bensussan
Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26): 16963–16968. Published online 2002 Dec 16. doi: 10.1073/pnas.012681099
PMCID:
PMC139252
AbstractArticlePDF–261K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center